Last update 08 May 2025

House dust mite allergy extract(Stallergenes SA)

Overview

Basic Info

Drug Type
Allergen extract
Synonyms
Oralair Mites
+ [6]
Target-
Action
modulators
Mechanism
Immunomodulators
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (26 Mar 2015),
RegulationOrphan Drug (South Korea)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Allergic asthma
Australia
15 Apr 2016
Rhinitis, Allergic, Perennial
Japan
26 Mar 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AnaphylaxisPhase 3
Bulgaria
14 Nov 2023
AnaphylaxisPhase 3
Romania
14 Nov 2023
AnaphylaxisPhase 3
Lithuania
14 Nov 2023
AnaphylaxisPhase 3
Latvia
14 Nov 2023
AnaphylaxisPhase 3
Germany
14 Nov 2023
allergic rhinitis due to dust mitePreclinical-20 Nov 2018
House dust mite allergyPreclinical
United States
29 Sep 2015
House dust mite allergyPreclinical
France
29 Sep 2015
Rhinitis, Allergic, PerennialPreclinical
United States
29 Sep 2015
Rhinitis, Allergic, PerennialPreclinical
France
29 Sep 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
509
fihvdrzauw(alrdqwxtel) = motrlljytb nftqjvlhem (tyihhvobzg, uttmrmgwpj - svyedrmymc)
-
19 May 2016
fihvdrzauw(alrdqwxtel) = esprrtvqdz nftqjvlhem (tyihhvobzg, pzhlatyrti - dsvdpwcxpd)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free